[Federal Register Volume 69, Number 129 (Wednesday, July 7, 2004)]
[Rules and Regulations]
[Pages 40765-40766]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-15425]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 510 and 522


Implantation or Injectable Dosage Form New Animal Drugs; 
Cloprostenol Sodium

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Final rule.

-----------------------------------------------------------------------

[[Page 40766]]

SUMMARY:  The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect approval of an abbreviated new animal drug 
application (ANADA) filed by Parnell Laboratories (Aust) Pty. Ltd. The 
ANADA provides for the veterinary prescription use of cloprostenol 
sodium injectable solution in cattle for manipulation of the estrous 
cycle.

DATES:  This rule is effective July 7, 2004.

FOR FURTHER INFORMATION CONTACT:  Lonnie W. Luther, Center for 
Veterinary Medicine (HFV-104), Food and Drug Administration, 7519 
Standish Pl., Rockville, MD 20855, 301-827-8549, e-mail: 
[email protected].

SUPPLEMENTARY INFORMATION: Parnell Laboratories (Aust) Pty. Ltd., 
Century Estate, unit 6, 476 Gardeners Rd., Alexandria, New South Wales 
2015, Australia, filed ANADA 200-310 for the use of ESTROPLAN 
(cloprostenol sodium) Injection by veterinary prescription for 
manipulation of the estrous cycle of cattle. Parnell Laboratories 
(Aust) Pty. Ltd.'s ESTROPLAN Injection is approved as a generic copy of 
Schering-Plough Animal Health Corp.'s ESTRUMATE, approved under NADA 
113-645. The ANADA is approved as of May 13, 2004, and the regulations 
are amended in 21 CFR 522.460 to reflect the approval. The basis of 
approval is discussed in the freedom of information summary.
    In addition, Parnell Laboratories (Aust) Pty. Ltd., is not 
currently listed in the animal drug regulations as a sponsor of an 
approved application. At this time, 21 CFR 510.600(c) is being amended 
to add entries for the firm.
    In accordance with the freedom of information provisions of 21 CFR 
part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and 
effectiveness data and information submitted to support approval of 
this application may be seen in the Division of Dockets Management 
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
    The agency has determined under 21 CFR 25.33(a)(1) that this action 
is of a type that does not individually or cumulatively have a 
significant effect on the human environment. Therefore, neither an 
environmental assessment nor an environmental impact statement is 
required.
    This rule does not meet the definition of ``rule'' in 5 U.S.C. 
804(3)(A) because it is a rule of ``particular applicability.'' 
Therefore, it is not subject to the congressional review requirements 
in 5 U.S.C. 801-808.

List of Subjects

21 CFR Part 510

    Administrative practice and procedure, Animal drugs, Labeling, 
Reporting and recordkeeping requirements.

21 CFR Part 522

    Animal drugs.

0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 
522 are amended as follows:

PART 510--NEW ANIMAL DRUGS

0
1. The authority citation for 21 CFR part 510 continues to read as 
follows:

    Authority:  21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

0
2. Section 510.600 is amended in the table in paragraph (c)(1) by 
alphabetically adding an entry for ``Parnell Laboratories (Aust) Pty. 
Ltd.''; and in the table in paragraph (c)(2) by numerically adding an 
entry for ``068504'' to read as follows:


Sec.  510.600   Names, addresses, and drug labeler codes of sponsors of 
approved applications.

* * * * *
    (c) * * *
    (1) * * *

------------------------------------------------------------------------
              Firm name and address                 Drug  labeler code
------------------------------------------------------------------------
                                * * * * *
Parnell Laboratories (Aust) Pty. Ltd., Century    068504
 Estate, unit 6, 476 Gardeners Rd., Alexandria,
 New South Wales 2015, Australia
                                * * * * *
------------------------------------------------------------------------

    (2) * * *

------------------------------------------------------------------------
   Drug  labeler code                 Firm name and address
------------------------------------------------------------------------
                                * * * * *
068504                   Parnell Laboratories (Aust) Pty. Ltd., Century
                          Estate, unit 6, 476 Gardeners Rd., Alexandria,
                          New South Wales 2015, Australia
                                * * * * *
------------------------------------------------------------------------

PART 522--IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

0
3. The authority citation for 21 CFR part 522 continues to read as 
follows:

    Authority:  21 U.S.C. 360b.


Sec.  522.460   [Amended]

0
4. Section 522.460 is amended in paragraph (a)(2) by removing ``No. 
000061'' and by adding in its place ``Nos. 000061 and 068504''.

    Dated: June 17, 2004.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. 04-15425 Filed 7-6-04; 8:45 am]
BILLING CODE 4160-01-S